BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen S, Evert B, Adeniyi A, Salla-Martret M, Lua LH, Ozberk V, Pandey M, Good MF, Suhrbier A, Halfmann P, Kawaoka Y, Rehm BHA. Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity. Adv Healthc Mater 2022;11:e2102089. [PMID: 34716678 DOI: 10.1002/adhm.202102089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Azali MA, Mohamed S, Harun A, Hussain FA, Shamsuddin S, Johan MF. Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review. J Genet Eng Biotechnol 2022;20:98. [PMID: 35792966 DOI: 10.1186/s43141-022-00368-7] [Reference Citation Analysis]
2 Borbone N, Piccialli I, Falanga AP, Piccialli V, Roviello GN, Oliviero G. Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era. IJMS 2022;23:4359. [DOI: 10.3390/ijms23084359] [Reference Citation Analysis]
3 Evert BJ, Chen S, McConville R, Steel RWJ, Healer J, Boddey JA, Huntimer L, Rehm BHA. Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites. NPJ Vaccines 2021;6:141. [PMID: 34845267 DOI: 10.1038/s41541-021-00408-2] [Reference Citation Analysis]
4 Gonzaga ZJC, Chen S, Lehoux M, Segura M, Rehm BHA. Engineering Antigens to Assemble into Polymer Particle Vaccines for Prevention of Streptococcus suis Infection. Vaccines (Basel) 2021;9:1386. [PMID: 34960132 DOI: 10.3390/vaccines9121386] [Reference Citation Analysis]